European journal of clinical investigation
-
Eur. J. Clin. Invest. · Mar 2021
Randomized Controlled TrialThe value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia.
This study aimed to investigate the value of high-flow nasal cannula (HNFC) oxygen therapy in treating patients with severe novel coronavirus pneumonia (COVID-19). ⋯ Compared with COT, early application of HFNC oxygen therapy in patients with severe COVID-19 can improve oxygenation and RR, and HFNC oxygen therapy can improve the infection indexes of patients and reduce the length of stay in the ICU of patients. Therefore, it has high clinical application value.